• 1. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 4. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,4,5-trisubstituted thiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles 2,4,5-trisubstituted thiazoles

Recent Advances in the Study of 2-Amino-4-(trifluoromethyl)thiazole-5-carbaldehyde (CAS: 933683-99-9)

2-Amino-4-(trifluoromethyl)thiazole-5-carbaldehyde (CAS: 933683-99-9) is a key intermediate in the synthesis of various biologically active compounds, particularly in the fields of medicinal chemistry and drug discovery. Recent studies have highlighted its significance in the development of novel therapeutic agents, owing to its unique structural features and reactivity. This research briefing provides an overview of the latest advancements related to this compound, focusing on its synthesis, applications, and potential therapeutic implications.

One of the most notable developments in recent research is the optimization of synthetic routes for 2-Amino-4-(trifluoromethyl)thiazole-5-carbaldehyde. A study published in the Journal of Medicinal Chemistry (2023) demonstrated an improved synthetic protocol that enhances yield and purity while reducing environmental impact. The method involves a one-pot condensation reaction under mild conditions, making it more scalable for industrial applications. This advancement is particularly relevant for pharmaceutical companies aiming to produce this intermediate at a larger scale.

In addition to its synthetic utility, 2-Amino-4-(trifluoromethyl)thiazole-5-carbaldehyde has been investigated as a building block for the development of kinase inhibitors. Recent preclinical studies have shown that derivatives of this compound exhibit potent inhibitory activity against specific kinases involved in cancer progression. For instance, a research team at a leading academic institution reported that a series of thiazole-based compounds derived from this aldehyde showed promising results in inhibiting tumor growth in vitro and in vivo. These findings were published in a high-impact journal, underscoring the compound's potential in oncology drug development.

Another area of interest is the application of 2-Amino-4-(trifluoromethyl)thiazole-5-carbaldehyde in the design of antimicrobial agents. A 2024 study explored its incorporation into novel thiazole derivatives with broad-spectrum activity against drug-resistant bacterial strains. The researchers noted that the trifluoromethyl group plays a crucial role in enhancing the compounds' bioavailability and metabolic stability, making them attractive candidates for further development. This research aligns with the growing need for new antibiotics to address the global challenge of antimicrobial resistance.

Beyond its direct therapeutic applications, recent computational studies have provided insights into the molecular interactions of 2-Amino-4-(trifluoromethyl)thiazole-5-carbaldehyde with biological targets. Molecular docking and dynamics simulations have revealed favorable binding modes with various enzymes and receptors, suggesting its versatility in drug design. These in silico findings complement experimental data and offer a rational basis for the compound's continued exploration in medicinal chemistry.

In conclusion, 2-Amino-4-(trifluoromethyl)thiazole-5-carbaldehyde (CAS: 933683-99-9) remains a compound of significant interest in chemical biology and pharmaceutical research. Recent advancements in its synthesis, coupled with its demonstrated potential in multiple therapeutic areas, position it as a valuable intermediate for future drug discovery efforts. Ongoing studies are expected to further elucidate its mechanisms of action and expand its applications in addressing unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)